hli logo
Image from Coce

Prostate cancer : science and clinical practice / edited by Jack H. Mydlo, Ciril J. Godec.

Contributor(s): Material type: TextTextPublisher: London : Academic Press is an imprint of Elsevier, [2016]Copyright date: ©2016Description: 1 online resource (xix, 639 pages) : illustrations (chiefly color)Content type:
  • text
  • still image
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9780128005927
  • 0128005920
Uniform titles:
  • Prostate cancer (Mydlo)
  • Preceded by: Prostate cancer.
Subject(s): Genre/Form: Additional physical formats: Print version:: Prostate cancer.DDC classification:
  • 616.99/463 23
LOC classification:
  • RC280.P7
NLM classification:
  • WJ 762
Online resources:
Contents:
Population screening for prostate cancer and early detection -- Inflammation and infection in the etiology of prostate cancer -- Androgen receptor -- Novel research on fusion genes and next-generation sequencing -- Should Gleason score 6 still be called cancer? -- High grade prostatic intraepithelial neoplasia and atypical glands -- Prostate cancer in the elderly -- Prostate cancer and other primary malignancies -- Biopsy prophylaxis, technique, complications, and repeat biopsies -- Total and free PSA, PCA3, PSA density and velocity -- Imaging in localized prostate cancer -- Prostate cancer prevention: strategies and realities -- Prostate-specific antigen screening guidelines -- Cancer of the prostate: incidence in the USA -- International trends in prostate cancer -- Race, ethnicity, marital status, literacy, and prostate cancer outcomes in the united states -- Hereditary prostate cancer -- Neuroendocrine prostate cancer -- Breast and prostate cancers: a comparison of two endocrinologic malignancies -- Heart healthy = prostate healthy and S.A.M. are the ideal "natural" recommendations for prostate cancer -- Effects of smoking, alcohol, and exercise on prostate cancer -- Environmental and occupational exposures and prostate cancer -- Level-1 data from the reduce study and the PCPT data -- Decision support for low-risk prostate cancer -- Active surveillance: rationale, patient selection, follow-up, and outcomes -- Preoperative risk assessment -- Is surgery still necessary for prostate cancer? -- Indications for pelvic lymphadenectomy -- The surgical anatomy of the prostate -- Radical retropubic prostatectomy -- Radiation-resistant prostate cancer and salvage prostatectomy -- Postradical prostatectomy incontinence -- Prognostic significance of positive surgical margins and other implications of pathology report -- Open versus robotic prostatectomy -- The technique of robotic nerve-sparing prostatectomy -- Anterior approach to robotic radical prostatectomy -- Posterior approach to robotic-assisted laparoscopic radical prostatectomy -- The technique of robotic nerve sparing prostatectomy: extraperitoneal approach -- Clinical and pathologic staging of prostate cancer -- Management of bladder neck contracture in the prostate cancer survivor -- Reimbursement for prostate cancer treatment -- Fundamentals of radiation treatment for prostate carcinoma -- techniques, radiation biology, and evidence base -- Radiation with hormonal therapy -- Brachytherapy for prostate cancer: an overview -- Intensity modulated radiotherapy and image guidance -- Proton beam therapy -- Radiotherapy after radical prostatectomy: adjuvant versus salvage approach -- Emerging modalities in radiation therapy for prostate cancer -- Management of PSA recurrences after radical prostatectomy -- Salvage therapy for locally recurrent prostate cancer after external beam radiation therapy -- Management of locally advanced (nonmetastatic) prostate cancer -- Androgen deprivation therapy: appropriate patients, timing to initiate ADT, and complications -- Bone health in prostate cancer -- Castration resistant prostate cancer: role of chemotherapy -- Antiandrogen monotherapy in the treatment of prostate cancer -- Sipuleucel-T -- a model for immunotherapy trial development -- Second-line hormonal for castrate-resistant prostate cancer -- Salvage cryoablation of the prostate -- High-intensity focused ultrasound -- Focal therapy for prostate cancer -- Quality of life: impact of prostate cancer and its treatment -- Impact of prostate cancer treatments on sexual health -- Coding and billing for diagnosis and treatment of prostate cancer -- Health policy for prostate cancer: PSA screening as case study -- Legal implications of prostate cancer screening -- New markers for prostate cancer detection and prognosis -- Testosterone therapy in hypogonadal men with prostate cancer.
Summary: This book reviews the biological processes that can be implicated in the disease, reviews current treatments, highlights the pitfalls where relevant, and examines the scientific developments that might result in future treatments.
Item type: eBook List(s) this item appears in: National ClinicalKey eBooks
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Collection Shelving location Call number Status Date due Barcode Item holds
eBook eBook eLibrary eLibrary Health Library Ireland eBook Collection online ebook Available EB1174
Total holds: 0

Revised edition of: Prostate cancer : science and clinical practice / [edited by] Jack H. Mydlo, Ciril J. Godec. ©2003.

Includes bibliographical references.

Population screening for prostate cancer and early detection -- Inflammation and infection in the etiology of prostate cancer -- Androgen receptor -- Novel research on fusion genes and next-generation sequencing -- Should Gleason score 6 still be called cancer? -- High grade prostatic intraepithelial neoplasia and atypical glands -- Prostate cancer in the elderly -- Prostate cancer and other primary malignancies -- Biopsy prophylaxis, technique, complications, and repeat biopsies -- Total and free PSA, PCA3, PSA density and velocity -- Imaging in localized prostate cancer -- Prostate cancer prevention: strategies and realities -- Prostate-specific antigen screening guidelines -- Cancer of the prostate: incidence in the USA -- International trends in prostate cancer -- Race, ethnicity, marital status, literacy, and prostate cancer outcomes in the united states -- Hereditary prostate cancer -- Neuroendocrine prostate cancer -- Breast and prostate cancers: a comparison of two endocrinologic malignancies -- Heart healthy = prostate healthy and S.A.M. are the ideal "natural" recommendations for prostate cancer -- Effects of smoking, alcohol, and exercise on prostate cancer -- Environmental and occupational exposures and prostate cancer -- Level-1 data from the reduce study and the PCPT data -- Decision support for low-risk prostate cancer -- Active surveillance: rationale, patient selection, follow-up, and outcomes -- Preoperative risk assessment -- Is surgery still necessary for prostate cancer? -- Indications for pelvic lymphadenectomy -- The surgical anatomy of the prostate -- Radical retropubic prostatectomy -- Radiation-resistant prostate cancer and salvage prostatectomy -- Postradical prostatectomy incontinence -- Prognostic significance of positive surgical margins and other implications of pathology report -- Open versus robotic prostatectomy -- The technique of robotic nerve-sparing prostatectomy -- Anterior approach to robotic radical prostatectomy -- Posterior approach to robotic-assisted laparoscopic radical prostatectomy -- The technique of robotic nerve sparing prostatectomy: extraperitoneal approach -- Clinical and pathologic staging of prostate cancer -- Management of bladder neck contracture in the prostate cancer survivor -- Reimbursement for prostate cancer treatment -- Fundamentals of radiation treatment for prostate carcinoma -- techniques, radiation biology, and evidence base -- Radiation with hormonal therapy -- Brachytherapy for prostate cancer: an overview -- Intensity modulated radiotherapy and image guidance -- Proton beam therapy -- Radiotherapy after radical prostatectomy: adjuvant versus salvage approach -- Emerging modalities in radiation therapy for prostate cancer -- Management of PSA recurrences after radical prostatectomy -- Salvage therapy for locally recurrent prostate cancer after external beam radiation therapy -- Management of locally advanced (nonmetastatic) prostate cancer -- Androgen deprivation therapy: appropriate patients, timing to initiate ADT, and complications -- Bone health in prostate cancer -- Castration resistant prostate cancer: role of chemotherapy -- Antiandrogen monotherapy in the treatment of prostate cancer -- Sipuleucel-T -- a model for immunotherapy trial development -- Second-line hormonal for castrate-resistant prostate cancer -- Salvage cryoablation of the prostate -- High-intensity focused ultrasound -- Focal therapy for prostate cancer -- Quality of life: impact of prostate cancer and its treatment -- Impact of prostate cancer treatments on sexual health -- Coding and billing for diagnosis and treatment of prostate cancer -- Health policy for prostate cancer: PSA screening as case study -- Legal implications of prostate cancer screening -- New markers for prostate cancer detection and prognosis -- Testosterone therapy in hypogonadal men with prostate cancer.

Online resource; title from resource home page (ClinicalKey, viewed May 10, 2017).

This book reviews the biological processes that can be implicated in the disease, reviews current treatments, highlights the pitfalls where relevant, and examines the scientific developments that might result in future treatments.

Elsevier Elsevier ClinicalKey eBooks - WAYFless access

There are no comments on this title.

to post a comment.